Skip to main content

Navigation group

Type at least 3 characters
36,317 articles

Articles

Original Research

Published on 02 Feb 2021

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies

in Alloimmunity and Transplantation

  • Agnieszka Tomaszewska
  • Madan Jagasia
  • Eric Beohou
  • Steffie van der Werf
  • Didier Blaise
  • Edward Kanfer
  • Noel Milpied
  • Péter Reményi
  • Fabio Ciceri
  • Jean H. Bourhis
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Frontiers in Immunology
doi 10.3389/fimmu.2020.613954
  • 2,596 views
  • 1 citation